Clinical trial / 2001
Oral green tea extract was tolerated up to six months in cancer patients.
A phase I trial assessed the safety and pharmacokinetics of oral green tea extract in 49 adults with solid tumors over four weeks to six months. The maximum tolerated intake reached 4.2 g/m² given once per day or 1.0 g/m² taken thrice daily. Side effects were mild to moderate, primarily caffeine-related, and 10 individuals achieved stable disease.
- Study type
- Phase 1 clinical trial
- Who was studied
- 49 adults with solid tumors
- What was measured
- Maximum-tolerated dose, toxicity, and pharmacokinetics
THE PAPER
Phase I trial of oral green tea extract in adult patients with solid tumors.
Pisters KM, Newman RA, Coldman B, Shin DM, Khuri FR, Hong WK, Glisson BS, Lee JS. J Clin Oncol, 2001.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.